DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Shivaprakash G, Udupa KS, Sarayu V, Thomas J, Gupta V, Pallavi LC. et al.
Olanzapine versus aprepitant for the prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving doxorubicin-cyclophosphamide regimen: A prospective, nonrandomized, open-label study.
Indian J Pharmacol 2017;
49: 451-7
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.